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BLOOD GASES AND RETINOPATHY OF PREMATURITY: THE EXTREMELY 
LOW GESTATIONAL AGE NEWBORN STUDY. Alisse K. Hauspurg and Richard 
A. Ehrenkranz. Department of Pediatrics, Yale Univeristy School of Medicine, 
New Haven, CT. 
 
This study tested the hypothesis that preterm infants who had a blood gas 
derangement on at least 2 of the first 3 postnatal days are at increased risk for 
more severe retinopathy of prematurity (ROP). 1,042 infants born before 28 
weeks’ gestational age (GA) were included. An infant was considered at risk if 
his/her blood gas measure was in the highest or lowest quartile for GA on at least 
2 of the first 3 postnatal days. Multivariable models adjusting for confounders 
indicate that exposure to a PCO2 in the highest quartile predicts ROP stage 3, 4 
or 5: (OR = 1.6, 95% CI = 1.1–2.3); zone 1: 2.0, 1.1–3.6; prethreshold/threshold: 
1.9, 1.2–3.0; plus disease: 1.8, 1.1–2.9. Estimates are similar for a low pH for 
zone 1 (2.1, 1.2–3.8), prethreshold/threshold (1.8, 1.1–2.8), but did not quite 
achieve statistical significance for ROP stage 3, 4, or 5 (1.4, 0.9–2.0) and plus 
disease (1.5, 0.9–2.4). A PaO2 in the highest quartile for GA on at least 2 of the 
first 3 postnatal days was associated with a doubling of the risk of ROP in zone 1 
(2.5, 1.4–4.4) and of prethreshold/threshold disease (2.1, 1.4–3.3), a 70% risk 
increase for plus disease (1.7, 1.04–2.8), while a 40% risk increase for ROP 
stage 3 or higher did not achieve statistical significance (1.4, 0.96–2.0). Infants 
who experienced high PCO2, low pH and high PaO2 during the first three prenatal 
days appear to be at increased risk of more severe ROP. 
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 5 
Introduction 
Extremely Low Gestational Age Newborns (ELGANs), or infants born at 
less than 28 weeks gestational age (GA), are at a high risk of developing 
retinopathy of prematurity (ROP), a developmental vascular disorder that is one 
of the most common causes of pediatric blindness in the United States (1,2). The 
smallest, most preterm infants, who have an increased survival rate with recent 
advances in neonatal care, also experience the most severe forms of ROP (3). 
The history of ROP dates back to its initial discovery by Dr. Theodore L. 
Terry in 1942. Terry described an infant with grey, blood vessel-covered 
membranes behind its pupil, and hypothesized that "some new factor has arisen 
in extreme prematurity to produce such a condition." As the number of described 
cases increased, the condition became known as retrolental fibroplasia (RLF). 
One of the factors Terry originally considered in his early case reports was the 
excess exposure of premature infants to light, leading to early activation of 
pupillary and ciliary body musculature (4). Other factors he suggested could be 
contributing to the development of RLF included genetic factors, premature 
closure of the ductus arteriosus and foramen ovale, hyperoxia, hypoxia, 
hypothermia or endocrine factors (5).  
It was noted to be increasingly common in premature infants, and it was 
recognized that infants were not born with RLF but rather developed it after birth 
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(6).  Researchers continued to suggest various theories to explain and attempt to 
prevent this epidemic of blindness, including maternal factors, multiple 
gestations, infection, poor nutrition, iron deficiency, and other vitamin deficiencies 
(7). 
 As multiple risk factors leading to RLF were examined and dismissed, the 
prominent role of oxygen in its development was discovered with the first 
multicenter randomized controlled trial conducted by Kinsey and Hemphill (8). 
This study challenged the standard practice of administering 50% oxygen to 
premature infants in the first 4 weeks of life to prevent apnea of prematurity. 
Instead, infants randomized to the experimental group received room air oxygen 
unless they became cyanotic, at which point oxygen administration was 
increased, however, never to above 50%. Infants who received lower levels of 
oxygen developed RLF at much lower rates and with much less severity.  Many 
did not develop RLF at all. The results of this trial were the first evidence of the 
role that oxygen played in the development of RLF. Following this, clinicians and 
researchers alike attributed the development of RLF to excess oxygen exposure 
alone, and thus, oxygen use was restricted in nurseries (8). 
During this time, many researchers observed that in some cases RLF 
occurred with similar frequency in infants who did not receive oxygen. These 
cases were initially thought to be exceptions to the rule, and many were 
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dismissed as anomalies. In fact, many authors during this time called attention to 
the weakness of the oxygen hypothesis, but their criticism was largely ignored 
(7). Throughout the 1950s and 1960s, RLF nearly disappeared. Medical students 
were hardly taught about it, as it was thought to be a condition of past mistakes 
in neonatology. However, it is worth noting that despite tight control on oxygen 
administration to preterm infants, there were still a number of cases of RLF 
described. 
During this time the “40% rule” arose in many clinical centers, which 
emphasized that 40% oxygen was safe for the eyes of premature infants, but any 
higher level of oxygen was dangerous. Despite the seeming protection of infants’ 
eyes from RLF with the curtailing of oxygen, neonatal mortality actually rose, as 
did spastic diplegia (9). Later investigations estimated that for every case of 
blindness prevented with control of oxygen therapy, approximately 16 infants 
died secondary to inadequate oxygenation (10). Following these developments, 
researchers began to advocate more “judicious” use of oxygen in the mid-1960s. 
 However, it warrants mention that during this time, there were no 
intravenous fluids, and no ventilators, thus there were very few interventions 
performed by neonatologists during these years. As these modalities of care 
were implemented in neonatal intensive care units in the mid-1970s, survival of 
preterm infants significantly improved. With improved survival at increasingly low 
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gestational ages, however, came a reemergence of RLF at extremely high rates, 
which could no longer be solely attributed to high oxygen exposure (7).  
Animal studies conducted during this period seemed to suggest that it was 
not only oxygen, but also the degree of prematurity of the eye that was among 
the critical risk factors for development of the disease. Secondary to these 
findings, RLF was renamed retinopathy of prematurity (ROP). It was 
subsequently found that the greater the degree of immaturity of the eye (or 
prematurity of the infant) the greater the risk of ROP (7). Techniques began to 
develop to provide optimum oxygen amounts to maximize survival without 
damage to the brain, while attempting to minimize the risks of development of 
ROP. However, during this period, a second epidemic of ROP occurred, in spite 
of attempts to carefully control oxygen therapy. Researchers estimated that 
during this second epidemic, the number of infants blinded by ROP each year 
was comparable to the number blinded during the first epidemic, which spanned 
ten years between 1943 and 1953 (7). 
In spite of the seemingly widespread recognition of the existence of ROP 
and the extensive research into predisposing factors for its development, there 
was no universal method of classifying the progression of ROP or its severity 
until the early 1980s. The classification system, International Classification of 
ROP (ICROP) was developed by neonatologists and ophthalmologists together 
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and first described in the literature in 1984. The ICROP system utilizes several 
different components to classify ROP, including position (zone), severity (stage), 
extent (clock hours) and presence or absence of plus disease (12). For a visual 
depiction of the ICROP classification system, see figure 1. 
In terms of zones of the retina, ICROP describes three zones; with vessels 
growing from the optic disc initially crossing zone I, then zone II, and finally 
crossing zone III to reach the ora serrata. The blood vessels grow from the optic 
disc beginning at approximately 16 weeks GA, as such, the more premature an 
infant is, the less progress the vessels will have made towards the ora serrata. 
Thus, ROP seen in zone I initially has a much worse prognosis than that of ROP 
seen in zone III, which generally has a more benign, milder course (12). 
Similarly, classification of stages of ROP is based on the overproduction of 
vessels at the transition between the vascularized and avascular retina. The 
abnormal vascular response at the junction of the vascularized and avascular 
retina is classified as stage 1 through stage 5, with stage 5 representing the most 
severe disease. Stage 1 is characterized by a thin demarcation line separating 
the vascularized retina anteriorly from the avascular retina posteriorly. There is 
abnormal branching of vessels leading up to the demarcation line. In stage 1 
ROP, the line is relatively flat, white and is within the same plane as the retina. 
Stage 2 ROP is characterized by the progression of the demarcation line in stage 
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1 into a ridge. The ridge has height, width and extends above the retinal plane, in 
contrast to the demarcation line, which, as previously mentioned is relatively flat. 
In stage 3 disease immature vessels break through the retina, and this 
neovascularization extends from the ridge into the vitreous.  For a visual 
depiction of the progression of the demarcation line from stage 1 through stage 3 
ROP, see figure 2. Stage 4 disease is characterized by partial retinal 
detachment. Finally, stage 5 ROP, the most severe stage, represents complete 
detachment of the retina (13). For more detailed descriptions of specific retinal 
findings associated with each ROP stage, see table 1. 
The clock hours, or extent classification describes the number of clock 
hours of the zone that contains the stage of ROP identified, and further serves to 
describe the degree of ROP present (12). For a visual depiction of the clock 
hours classification, see figure 1. 
 Finally, “plus disease” is encompassed by a “waviness” of the retinal 
vessels, which represents increased venous dilatation and arteriolar tortuosity of 
the posterior retinal vessels (see figure 2). This finding is concerning, because it 
is thought that the most severe type of ROP that leads to retinal detachment 
always progresses through plus disease prior to retinal detachment (12). It can 
later increase in severity to include iris vascular engorgement, a rigid pupil and a 
vitreous haze (13).  
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Subsequently, in clinical trials testing the efficacy of cryotherapy for ROP, 
further definitions of ROP were developed. “Threshold” ROP is defined as ROP 
in either zone I or zone II, at least 5 continuous or 8 composite clock hours of 
stage 3 and plus disease. This classification was found to be clinically useful in 
that untreated threshold ROP progresses to retinal detachment about half the 
time. “Prethreshold” ROP represents less severe disease and is used more as a 
marker for identifying infants at risk for progression to threshold disease and 
requiring more frequent eye examinations (12). 
There are two other classifications of the disease that were described as 
recently as 2005 (13), and reflect the changing nature of our understanding of the 
progression of ROP. Pre-plus disease is defined as vascular abnormalities of the 
posterior pole that demonstrate more arterial tortuosity than normal but do not 
meet the diagnostic criteria for plus disease. Over time, the abnormalities of pre-
plus disease may progress to plus disease as the vessels become more tortuous 
(13). 
A less common, but rapidly progressive, severe form of ROP was also first 
defined in the literature in 2005 (13), and is termed aggressive posterior ROP 
(AP-ROP). It had been previously referred to as “type II ROP” or “Rush disease,” 
but it was not included in the initial publication of ICROP. This form of ROP is 
characterized by its posterior location, the prominence of plus disease and a 
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poorly defined nature of the retinopathy. Further, the diagnosis can be made on a 
single eye examination, and does not require evaluation over time. AP-ROP is 
most commonly observed in zone I, and may not progress through the classic 
stages 1 to 3. Finally, as AP-ROP can appear as only a flat area of 
neovascularization at the featureless junction between vascularized and 
nonvascularized retina, it can easily be overlooked by a lesser experienced 
clinician or examiner (13).  
The natural history of ROP is very clearly linked to GA, as infants born at 
less than 27 weeks almost always develop some degree of ROP. ROP is rarely 
seen prior to 4 weeks after delivery, and it occurs even later in infants born at 
lower gestational ages. Thus, ROP is most commonly seen after 31 weeks 
postmenstrual age (i.e. gestational age at birth plus chronological age). Once it 
begins, it typically involves only a few clock hours at stage 1 or 2, which 
eventually progress over time, however, the zone involved typically doesn’t 
change (12). Treatment for ROP involves cryoablation of the immature, 
nonvascularized retina at the periphery or laser photocoagulation to ablate the 
peripheral retina. Both interventions have been shown to be equally effective at 
reducing unfavorable visual outcomes (14).  
There is also evidence of the proven benefits of timely treatment of ROP 
in reducing the risk of visual loss, which has raised questions regarding optimal 
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screening guidelines (14). The American Academy of Pediatrics (AAP) recently 
published a policy statement outlining ROP screening guidelines for preterm 
infants. Recommendations address conditions for screening, timing of screening 
and treatment, follow-up and conditions for discontinuing screening (14).  
In terms of conditions for screening, infants born at less than 32 weeks or 
a birth weight of less than 1500 grams, or infants with an unstable clinical course 
should have a screening exam. One examination is appropriate only if it 
undoubtedly shows full retinal vascularization in both eyes. An ophthalmologist 
with sufficient knowledge and experience with ROP to enable accurate 
identification should perform exams with pupillary dilation. Initiation of screening 
is based on postmenstrual age (PMA), with most screening recommended 
between 31 and 36 weeks PMA (14).  
Follow-up screening exams are based on the severity of ROP noted on 
initial exam. Infants with stage 1 or 2 ROP in zone I or stage 3 ROP in zone II 
should have much closer follow-up, with a repeat exam occurring within 1 week 
or less. Infants with immature vascularization in zone I but no ROP, stage 2 ROP 
in zone II or regressing ROP in zone I should be reexamined within 1-2 weeks. 
Two-week follow-up can occur for infants with stage I or regressing ROP in zone 
II. Finally reexamination in 2-3 weeks is appropriate for infants with immature 
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vascularization with no ROP in zone II, stage 1 or 2 or regressing ROP in zone III 
(14).  
Infants that require treatment with peripheral ablation rather than follow-up 
screening include those with any plus disease, zone 1 ROP at any stage with 
plus disease or at stage 3 with no plus disease or zone II, stage 2 or 3 with plus 
disease. The AAP recommends treatment within 72 hours of identifying treatable 
disease to minimize progression to retinal detachment. Infants should continue to 
be screened at the aforementioned intervals until they have attained findings that 
are appropriate for conclusion of screening. Those conditions include attainment 
of zone III retinal vascularization without previous zone I or II ROP, full retinal 
vascularization, PMA of 45 weeks and no prethreshold disease, or regression of 
ROP (14). 
The basis for the current screening and treatment guidelines comes from 
a number of clinical trials conducted over the previous two decades. Stemming 
from Terry’s initial hypothesis regarding the exposure of premature infants to 
excess light, the LIGHT-ROP trial (15) tested the long-held belief that hospital-
nursery lighting contributes to the development of ROP. This study found that a 
reduction in ambient-light exposure did not in fact change the incidence of ROP 
(15). The Multicenter Trial of Cryotherapy for Retinopathy of Prematurity or the 
CRYO-ROP trial (16) began in 1986. This trial was conducted to evaluate the 
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safety and efficacy of cryotherapy for ROP and also to determine the long-term 
outcomes of eyes with threshold ROP that were either treated with cryotherapy 
or left untreated. The authors found that cryotherapy reduces the risk of 
unfavorable retinal and functional outcomes from threshold ROP. Visual 
outcomes at ten years of age supported the long-term safety and efficacy of 
cyrotherapy for threshold ROP (16).  
The authors of The Early Treatment for Retinopathy of Prematurity or the 
ETROP study (17) took CRYO-ROP a step further and sought to determine 
whether there was any benefit to early versus conventionally timed ablation of 
the peripheral retina. In this study, infants with bilateral high-risk prethreshold 
ROP had one eye randomized to early retinal ablation while the other eye was 
managed conservatively. This study found a significant reduction in unfavorable 
outcomes in high-risk prethreshold eyes that were treated earlier (17), and these 
results form the basis for current practice recommendations. 
There are also a number of studies evaluating optimal oxygenation for 
prevention of severe ROP. The Supplemental Therapeutic Oxygen for 
Prethreshold Retinopathy of Prematurity, or STOP-ROP trial (18) evaluated the 
safety of supplemental oxygen for infants with prethreshold ROP in reduction of 
progression to threshold ROP and need for eventual ablation. The study found 
that supplemental oxygen did not cause additional progression of prethreshold 
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ROP, but also did not significantly decrease the number of infants requiring 
ablation. The authors concluded that clinicians do not need to be concerned that 
supplemental oxygen will exacerbate prethreshold ROP (18). 
 The most recent trial evaluating optimal oxygenation in prevention of ROP 
is the SUPPORT trial (19), published in 2010. This trial randomized infants to 
target oxygen saturations with one group attaining values ranging from 85 to 89% 
and the other group to target saturations from 91 to 95% and studied whether 
there was a difference in severe ROP between the two groups. The authors 
found that the infants in the lower target range of oxygenation (85 to 89%) group 
did have a decrease in severe ROP among survivors; however, there was an 
increase in mortality among these infants (19). This increase in mortality is 
concerning given the present goals of lower target oxygen saturation to prevent 
ROP. These results call to mind the mistakes of neonatologists in the past, who 
were so restrictive with their use of oxygen that each case of blindness they 
prevented came at a cost of 16 infants’ lives (10). 
The pathophysiology of ROP has been extensively researched since the 
earliest studies linking its development to high oxygen levels. The most current 
understanding of the factors leading to the development of ROP come from both 
animal models and human studies, and are constantly being expanded upon. 
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The pathogenesis of ROP is biphasic, with an initial phase of retinal blood vessel 
degeneration followed by a second phase of neovascularization (20). 
  The first phase begins when retinal vascular growth ceases after 
premature birth. It is during this time when vessels are particularly susceptible to 
injury and can be obliterated by stressors such as oxygen supply and imbalance 
of growth factors. Notably, during this time, decreased vascular endothelial 
growth factor (VEGF) levels lead to suppression of vasoproliferation. This 
downregulation of VEGF is a direct result of the higher oxygen levels infants are 
exposed to after birth compared to the relative hypoxia in utero. VEGF 
expression is triggered by hypoxia, and its downregulation results in 
vasoobliteration of the retinal capillaries. This event is one of the first initiating 
events in the development of ROP (21).  
Subsequently, the relatively vascular-deplete retina becomes increasingly 
hypoxic – mainly secondary to its lack of an adequate blood supply as well as 
increased metabolic demands during its development. This hypoxia triggers the 
second, or vasoproliferative phase of ROP. During this phase there is an 
overproduction of hormones and growth factors in order to increase perfusion to 
the hypoxic retina. Specifically, there is an increase in production of VEGF, and 
other growth hormones, such as insulin-like growth factor 1 (IGF-1). These 
factors lead to the formation of new vessels in a non-organized, excessive 
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manner, and can lead to invasion of the vitreous, causing traction on the retina 
and also bleeding (21). This abnormal growth of vessels can produce a fibrous 
scar, which can retract and separate the retina from the retinal pigment 
epithelium, resulting in retinal distortion or detachment (22).  
Infants developing ROP are at risk not only for the retinal changes above 
but also for a multitude of other ocular abnormalities, including myopia, 
astigmatism, anisometropia and strabismus.  Further, increased severity of ROP 
is associated with increased prevalence and amount of myopia (23-25). 
Low gestational age and low birth weight are the strongest risk factors 
predicting ROP (26, 27).  Others include low IGF-1 levels (28), varying VEGF 
levels (29), systemic infection (30), inflammation (31), and genetic predisposition 
(32, 33). Intraventricular hemorrhage appears to be associated with ROP, 
probably because the same risk factors predispose very premature infants to 
both conditions (1, 34). 
Respiratory distress syndrome, and chronic in utero hypoxia also appear 
to be associated with an increased risk of ROP, presumably through the effects 
of respiratory dysfunction on arterial blood gases (35, 36).  Despite this, the role 
of blood gases and development of ROP is still unclear. Historically, as 
discussed earlier, high arterial oxygen levels were implicated in the development 
of ROP (37). However, more recently, widely fluctuating arterial oxygen tensions 
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and timing of high or low blood oxygen concentrations were better predictors of 
development and severity of ROP (38, 39). 
 
Hypothesis 
We hypothesized that ELGANs who have a blood gas extreme 
(abnormality) on at least two of the first three postnatal days are at a higher risk 
for more severe forms of ROP than infants who did not. 
 
 
Methods 
The ELGAN study was designed to identify characteristics and exposures 
that increase the risk of structural and functional neurologic disorders in ELGANs 
(40-46).  During the years 2002-2004, women delivering before 28 weeks 
gestation at one of 14 participating institutions in 11 cities in 5 states were asked 
to enroll in the study. The enrollment and consent processes were approved by 
the individual institutional review boards.  
Mothers were approached for consent either upon antenatal admission or 
shortly after delivery, depending on clinical circumstance and institutional 
preference. 1249 mothers of 1506 infants consented. A total of 464 of these 
infants died, were discharged before 36 weeks post-menstrual age, did not have 
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blood gas assessments on at least 2 of the first 3 postnatal days or did not have 
a retinal examination. The remaining 1042 infants comprise our sample for this 
report (Table 2).  
 
Demographic and pregnancy variables  
After delivery, a trained research nurse interviewed each mother in her 
native language using a structured data collection and following procedures 
contained in a manual. The mother’s report of her own characteristics and 
exposures, as well as the sequence of events leading to preterm delivery were 
taken as truth, even when her medical record provided discrepant information.  
Shortly after discharge, the research nurse reviewed the maternal chart 
using a second structured data collection form. The medical record was relied on 
for events following admission. The clinical circumstances that led to each 
maternal admission and ultimately to each preterm delivery were operationally 
defined using both data from the maternal interview and data abstracted from the 
medical record (46). 
 
Newborn variables 
The GA estimates were based on a hierarchy of the quality of available 
information. Most desirable were estimates based on the dates of embryo 
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retrieval or intrauterine insemination or fetal ultrasound before the 14th week 
(62%). When these were not available, reliance was placed sequentially on a 
fetal ultrasound at 14 or more weeks (29%), last menstrual period (LMP) without 
fetal ultrasound (7%), and GA recorded in the log of the neonatal intensive care 
unit (1%). The birth weight Z-score is the number of standard deviations the 
infant’s birth weight is above or below the median weight of infants at the same 
gestational age in a standard data set (47). 
 
Placentas 
Placental histology and bacterial presence was documented in an effort to 
characterize the relationship between placental characteristics, ROP severity and 
blood gas derangements. Delivered placentas were placed in a sterile exam 
basin and transported to a sampling room. Eighty-two percent of the samples 
were obtained within 1 hour of delivery.  The microbiologic procedures are 
described in detail elsewhere (48, 49).  
 
Blood gases 
 We classified ELGANs by their extreme blood gas measurements on 
postnatal days 1, 2, and 3. On each of these days, we collected information 
about the lowest, modal, and highest PaO2, PCO2, and pH.  In our sample, the 
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blood gas measurement that defined the extreme quartile varied by gestational 
age and by postnatal day (Table 3). We therefore classified infants by whether or 
not their extreme value each day was in the extreme quartile for their gestational 
age (23-24, 25-26, and 27 weeks).  Further, in order for an infant to be classified 
as having a blood gas in an extreme quartile, the blood gas value had to be less 
than (in the case of lowest quartiles) or greater than (in the case of highest 
quartiles) the defined value for each quartile. Because an extreme measure on 
one day could reflect a fleeting event, we required that an infant be in the 
extreme quartile on at least two of the three days to be considered “exposed” to 
such extremes. 
Our not having blood gas measurements on all three of the first three 
postnatal days might be an example of informative missingness. In essence, 
children who did not have a blood gas on postnatal day 3 were more likely to be 
physiologically stable than infants who had a set of blood gas measurements that 
day. These children who did not have day 3 measurements are also much less 
likely than others to have postnatal day 2 measurements that are in any extreme 
quartile. Assigning these non-extreme measurements to postnatal day 3 seems 
eminently reasonable, and allows us to include these children in this sample, and 
thereby avoids our inflating odds ratios inappropriately. 
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Eye examinations 
 Participating ophthalmologists helped prepare a manual and data 
collection form, and then participated in efforts to minimize observer variability.  
Definitions of terms were those accepted by the International Committee for 
Classification of ROP (12).  In keeping with guidelines (50), the first 
ophthalmologic examination was within the 31st to 33rd post-menstrual week. 
Follow-up exams were as clinically indicated until normal vascularization began 
in zone III. 
  
Data Analysis 
 The generalized form of the null hypotheses which we evaluated is that 
children who have a blood gas extreme (abnormality) on two of the first three 
postnatal days are not at higher risk of any form of ROP than children who did 
not have that blood gas extreme on two of the first three postnatal days.  We 
evaluated five blood gas extremes (lowest quartile of PaO2, highest quartile of 
PaO2, lowest quartile of PCO2, highest quartile of PCO2, lowest quartile of pH) in 
models that included the three of the other four blood gas extremes as well as 
other potential confounders.  All conditional logistic multivariable models included 
a hospital cluster term (to account for the probability that infants born at a 
particular hospital are more like each other than like infants born at other 
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hospitals) (51).  The contributions of relevant variables are presented as risk 
ratios with 95% confidence intervals. 
In this sample, children who had a PCO2 in the highest quartile tended to 
have a pH in the lowest quartile more commonly than expected if their co-
occurrence was independent of the other. As expected, models with both of 
these variables provided evidence that these two variables shared discriminating 
information. Consequently, we present two multivariable models for each ROP 
classification, Model 1 invariably includes a variable for low pH, but not a variable 
for high PCO2. Model 2, on the other hand, has a variable for high PCO2, but not 
a variable for low pH. 
We summarize some of our data with box and whiskers displays of the 
central tendency and dispersion of blood gases in ROP groups (Figure 3). The 
central tendency is indicated by the line close to the middle of the box, which is 
the median, and by the top and bottom of each box, which indicate the 25th and 
75th centiles. The dispersion of blood gases is indicated by the length of the 
vertical lines that emanate from the box, as well as by the block dots, which 
identify outliers. 
 Others involved in the study conducted the initial data collection for the 
larger database. For this project, I played a significant role in the study design 
along with Drs. Olaf Dammann and Alan Leviton. I analyzed the raw data from 
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the ELGAN database along with Elizabeth Allred. I complied the tables and 
figures, identified confounders and developed all the models described below 
along with Ms. Allred.  
 
 
Results 
Blood gas extremes were associated with an increased ROP risk on each 
postnatal day (Figure 3). We observed an upward trend for each postnatal day 
for oxygen and carbon dioxide extremes, with higher levels of each blood gas 
associated with more severe forms of ROP. Infants with more severe forms of 
ROP show a trend towards lower pH levels on each postnatal day. 
 
Maternal characteristics, illness and medication use (Table 4) 
  Infants of mothers who used aspirin had a considerably increased risk of 
developing more severe stages of ROP—nearly half of those infants developed 
stage 3+ ROP. Further, these infants also were more likely to experience an 
exposure to lower arterial blood oxygen and less likely to be exposed to higher 
arterial blood oxygen. Mothers with a white blood cell (WBC) count higher than 
20,000 within the interval before delivery to 48 hours post delivery were more 
likely to have infants with a more severe stage of ROP, with 35% of those infants 
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developing severe ROP. However, their infants were not at an increased risk of 
experiencing blood gas extremes. While maternal fever was not associated with 
having an infant at an increased risk of any stage of ROP, it was associated with 
increased exposure to CO2 levels in the highest quartile. 
 
Delivery characteristics (Table 4) 
Mothers with preeclampsia or a fetal indication for preterm delivery were 
more likely to have infants with more severe stages of ROP. In addition, infants 
of preeclamptic mothers were at a considerably greater risk for exposure to 
higher PCO2 levels. Infants delivered due to fetal indication were more likely to 
experience exposure to not just higher PCO2 levels, but also lower arterial 
oxygen levels and lower pH levels.  
 
Placenta bacteriology and histology (Table 5) 
 The presence of any mycoplasma in the placenta or thrombosis of fetal 
stem vessels was not associated with an increased risk of an infant’s 
development of ROP. However, infants with mycoplasma in their placentas were 
more likely to experience an exposure to lower CO2 and less likely to be exposed 
to higher CO2 levels. Infants with placentas with thrombosis of fetal stem vessels 
were more likely to be exposed to lower pH levels. Decidual hemorrhage or fibrin 
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deposition was associated with an increased risk for development of more severe 
ROP, with 32% of those infants developing stage 2 ROP, and 35% developing 
severe ROP. Decidual hemorrhage or fibrin deposition, however, were not 
associated with an increased risk of exposure to blood gas extremes.  
  
Infant characteristics (Table 6)  
Within each gestational age stratum, the blood gas values that defined the 
highest and lowest quartiles were consistently more extreme on the first three 
postnatal days for infants of lower gestational age (Table 3). Lower gestational 
age and lower birth weight Z-score was highly correlated with increased 
development of more severe forms of ROP. Fifty-four percent of infants born at 
23-24 weeks GA developed stage 3+ ROP compared to 31% of infants born 
between 25-26 weeks and just 11% of infants born at 27 weeks GA. Infants of 
lower birth weight and birth weight Z-score also developed more severe forms of 
ROP at a considerably increased rate. Nearly half of infants (49%) with a birth 
weight Z-score less than -2 developed stage 3+ ROP. These infants with the 
lowest birth weight Z-score were also much more likely to experience exposure 
to a lower pH or higher CO2 levels.  The same relationships hold true for infants 
with head circumference Z-scores, with infants with the lowest Z-scores more 
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likely to develop more severe forms of ROP and more likely to experience 
exposures to lower pH and higher PCO2.  
 
ROP severity classifications and blood gases (Table 7) 
Infants with stage 3 or higher ROP were more likely than their peers to be 
exposed to a high PaO2. Further, infants with plus disease were more likely than 
their peers to be exposed to a high PCO2 or low pH. Stratifying newborns by the 
presence/absence of zone 1 or prethreshold/ threshold disease resulted in even 
more prominent differences in hyperoxemia frequency, as well as prominent 
differences in frequencies of hypercapnia and acidemia. This increased 
difference is probably due to the fact that ‘stage 3 or higher’ includes ROP in all 
zones, thereby diluting the effect.   
 
Multi-variable analyses (Table 8)  
 After adjustment for confounders, our multivariable models indicated 
several significant relationships between blood gas extremes and ROP, which 
were more prominent when ROP was dichotomized by zone or pre- 
threshold/threshold than by stage. First, higher arterial O2 levels were 
significantly associated with zone 1, pre-threshold and threshold ROP, and the 
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presence of plus disease, while the association with stage 3 or higher disease 
did not reach statistical significance (both models). Second, high PCO2 levels 
were invariably significantly associated with increased risk of ROP stage 3 or 
higher, zone 1, pre- threshold and threshold ROP and the presence of plus 
disease (model 1). Third, very similar effects were present with exposure to low 
pH (model 2).  Infants who experienced high PCO2, low pH and high PaO2 
appear to be at an increased risk for development of more severe ROP, as will 
be further described below. 
Infants who experienced the highest PaO2 levels were 40% more likely to 
develop stage 3 or higher ROP in both models; model 1 (1.4, 0.95-2.0) and 
model 2 (1.4, 0.96-2.0). These infants were also significantly more likely to 
develop zone I disease; model 1 (2.5, 1.5-4.5) and model 2 (2.5, 1.4-4.4). They 
were also more than two times more likely to develop pre-threshold or threshold 
disease; model 1 (2.1, 1.3-3.3) and model 2 (2.1, 1.4-3.3). Finally, infants with a 
PaO2  in the highest quartile were 70% more likely to develop plus disease; 
model 1 (1.7, 1.02-2.7) and model 2 (1.7, 1.04-2.8).  
Likewise, infants who experienced the highest PCO2 levels were also 
much more likely than their peers to develop severe ROP in model 1. These 
infants were 60% more likely to develop stage 3 or higher (1.6, 1.1-2.3). They 
were significantly more likely to develop zone I disease (2.0, 1.1-3.6), and pre-
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threshold or threshold disease (1.9, 1.2-3.0). Finally, infants exposed to the 
highest quartile of PCO2  levels were 80% more likely to subsequently develop 
plus disease (1.8, 1.1-2.9). 
Similarly, infants exposed to the lowest pH levels were also much more 
likely to develop severe ROP in model 2. These infants were more likely to 
develop stage 3 or higher ROP (1.4, 0.9-2.0), although non-significantly. They 
were significantly more likely to develop zone I disease (2.1, 1.2-3.8). Infants with 
the lowest pH levels were 80% more likely to develop pre-threshold or threshold 
disease (1.8, 1.1-2.8). Finally, these infants were also more likely to develop plus 
disease (1.5, 0.9-2.4), although again, non-significantly. 
 
Discussion 
This is the first large-scale epidemiologic study showing an association 
between blood gas disturbances and risk of ROP development in ELGANs.  Our 
main finding is that exposure to high blood oxygen, high carbon dioxide 
concentrations or low pH is significantly associated with an increased risk of 
severe forms of ROP. These relationships remain statistically significant even 
after adjustment for confounders.  
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Hypercarbia and both metabolic and respiratory acidosis increase retinal 
neovascularization in animal models (52, 53).  These models propose that 
hypercarbia affects the retinal vasculature through vessel dilation, which can lead 
to increased oxygenation and increased retinal blood flow (54), which in turn may 
contribute to abnormal retinal vascularization (37). 
However, prior clinical studies assessing the role of blood gases in ROP 
development have yielded inconsistent results (39, 55). In a study of 91 
mechanically-ventilated infants of mean gestational age 29 weeks, a 
measurement of hypercarbia or hypocarbia on the first three postnatal days was 
not associated with an increased risk of ROP development (55).  The authors 
suggested that cumulative exposure integrated over time might be a better way 
to capture potentially adverse events than single measurements. Similar results 
were found in another underpowered study, of 25 infants less than 30 weeks 
gestational age, in which mean transcutaneous PCO2 was correlated to ROP 
development (56).  Both studies cited the need for further investigation with 
larger cohorts. Additionally, effects of pH on development of ROP have not been 
fully investigated in clinical studies, despite an abundance of evidence in animal 
models suggesting acidosis as a risk factor for ROP (52, 53). 
In contrast to the studies mentioned above, our study defined an exposure 
as a blood gas measure in the highest or lowest quartile for gestational age on 
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two of the first three postnatal days, rather than defining an upper limit, or using 
mean values.  In this way, we are able to better identify infants with an exposure 
to a blood gas extreme during the first three postnatal days.  
The infants in our study experienced PCO2 extremes that exceed the 
values defined as hypercarbia in previous studies (55).  We found that exposure 
to a PCO2 in the highest quartile was greatly associated with increased risk of 
severe ROP.  
Current clinical studies have not fully investigated or shown that 
decreased pH is associated with increased ROP severity. Our model showed 
that decreased pH is highly correlated with an increased risk of more severe 
forms of ROP. We speculate that there could be a potential role for early sepsis 
in the development of blood gas extremes and ROP severity. 
Finally, our study adds to our knowledge about arterial oxygen levels and 
ROP development. We found that exposure to higher arterial oxygen levels in the 
first three postnatal days is strongly associated with increased ROP severity. 
This is consistent with many current studies and the current clinical practice 
advocating the benefits of lower blood oxygen saturation during the first few 
weeks of life (57, 58). Several recent studies have found that lowering oxygen 
alarm limit parameters leads to a decreased risk of more severe forms of ROP 
(59), and better visual outcomes (60, 61). 
 33 
While the studies discussed above have not found a significant link 
between hypercarbia and ROP development, nor fully investigated the effects of 
pH extremes on development of ROP, they have alluded to the need for a larger 
sample size to generate more powerful data. Our study included 1042 ELGANs, 
of whom, 800 (77%) developed any stage of ROP. Compared to previous studies 
with sample sizes less than 100 infants, this is a huge increase in power. While 
most prior studies did not fully address confounding, we created a multivariable 
model adjusting for confounders. Consequently, we expect our results to provide 
a better understanding of the relationship between blood gas extremes and 
severity of ROP.  
The weaknesses of our study are those of all observational studies. We 
are unable to distinguish between causation and association as explanations for 
what we found by looking at the data only. Further, we assume that an extreme 
blood gas measure on two of the first three postnatal days constitutes an 
“exposure.” This definition was necessary considering the limits of our data, 
however, there is no published evidence for this definition. Finally, we are unable 
to differentiate between respiratory and metabolic acidosis, a clinically relevant 
distinction that is worth further investigation in future studies. 
In light of the biologic plausibility of our findings, we suggest that blood-
gas-associated ROP risk be considered in discussions of clinical practice. While 
 34 
oxygenation has dominated most of the recent ROP literature, the role of 
hypercarbia and acidosis in severe ROP may warrant further clinical 
consideration and study. This is especially important in light of recommendations 
about the safety and efficacy of ‘permissive hypercarbia’ (62). Permissive 
hypercarbia involves the adjustment of blood gas targets to allow higher than 
normal PCO2 levels in premature infants to prevent lung injury. While permitting 
higher PCO2 levels may indeed reduce ventilator-associated lung injuries, our 
findings concerning the effects of hypercarbia on development of severe ROP 
justify concerns raised in current discussions (63). 
 
 
Conclusion 
 In summary, we found that independent exposure to high PCO2, high PaO2 
or low pH during the first three days of life significantly increases risk of 
development of more severe forms of ROP. Further research might help better 
characterize such relationships and to develop more effective clinical parameters 
for safe blood gas levels in ELGANs. 
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Table 1. Description of retinal findings associated with each ROP stage 
on ophthalmologic examination (12). 
 
ROP Stage Retinal Findings 
 
No ROP Vessels fade from vascularized retina into avascular 
retina imperceptibly 
 
Stage 1 Distinct line or flat demarcation (usually white or 
yellowish) between transition from vascularized, 
posterior retina to avascular, peripheral retina 
 
Stage 2 Line (as described in stage 1 findings) becomes thicker 
in height and width, more three-dimensional now known 
as a ridge. Mass of growing immature vasculature, but 
contained within retina 
 
Stage 3 Vessels (as described in stage 2 findings) break 
through the retina into the vitreous space, also known 
as extraretinal neovascularization. This is source of 
arterio-venous shunting and contractile elements that 
can potentially lead to retinal detachment. 
 
Stage 4 Retina begins to become detached, lifted or pulled off 
choroidal bed 
 
Stage 5 Complete retinal detachment 
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Table 2. Sample description.    
      
 Yes No 
Enrolled 1506  
Survived to day 7 and had a head ultrasound 1414 92 
Had blood gas assessments on 2 days of days 1-3 1172 242 
Had a retinal examination 1042 130 
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Table 3. The values that define the highest and lowest quartiles of each 
blood gas displayed on the left on each day in each gestational age group. 
An infant is classified as having a blood gas in an extreme quartile, the blood 
gas value had to be less than (in the case of lowest quartiles) or greater than 
(in the case of highest quartiles) the defined value for each quartile. 
 
 
 
 
 
 
 
 
Blood Gas  Postnatal Gestational Age (weeks) 
 Day 23-24 25-26 27 
Lowest Quartile 1 40 42 40 
PaO2 (mmHg) 2 43 45 44 
 3 43 45 43 
Highest Quartile 1 152 145 143 
PaO2 (mmHg) 2 98 100 92 
 3 103 95 93 
Lowest Quartile 1 27 29 29 
PCO2 (mmHg) 2 33 35 35 
 3 33 33 35 
Highest Quartile 1 65 67 63 
PCO2 (mmHg) 2 60 64 60 
 3 58 57 56 
Lowest Quartile 1 7.15 7.20 7.22 
pH 2 7.14 7.17 7.22 
 3 7.16 7.19 7.22 
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Table 4. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for gestational age 
listed at the top of each column on at least two of the first three postnatal days in categories of maternal characteristics, 
maternal illness and medication use and delivery characteristics. These are row percents.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               Ø White blood cell count (WBC) within the interval from before delivery to 48 hours post delivery 
Maternal/Delivery 
Characteristic 
Blood Gas Extreme ROP Stage 
 
 Lowest 
PaO2 
Highest 
PaO2 
Lowest 
PCO2 
Highest 
PCO2 
Lowest 
pH N None 1 2 3+ N 
Pre-
pregnancy 
BMI 
< 18.5 21 18 26 28 26 76 29 26 20 25 91 
≥ 18.5, < 25 24 19 21 23 21 559 26 23 23 28 580 
≥ 25, < 30 19 27 21 18 21 224 28 21 23 28 230 
≥ 30 21 22 23 21 24 256 26 19 23 32 248 
Conception 
assistance 
Yes 24 18 17 28 23 232 28 21 21 30 246 
No 21 22 24 20 22 897 26 22 23 28 916 
Fever 
Yes 25 24 20 35 23 71 27 22 26 26 74 
No 22 21 23 21 22 1058 26 22 23 29 1088 
Aspirin use 
Yes 31 13 23 21 25 61 21 18 18 44 62 
No 21 22 22 22 22 1062 27 22 23 28 1095 
Highest 
WBCØ 
> 20K 24 23 18 21 16 233 23 22 20 35 241 
≤ 20K 21 20 23 22 23 913 27 22 23 28 936 
Initiator of 
delivery 
PTL 19 20 21 18 18 531 25 25 22 28 537 
PPROM 26 21 26 21 23 240 32 20 20 28 261 
Pre-
eclampsia 26 29 22 31 26 154 23 18 24 37 154 
Abruption 12 20 26 24 21 122 25 25 25 25 126 
Cervical 
insufficiency 23 22 16 19 23 73 30 17 27 27 71 
Fetal 
indication 40 17 13 35 37 52 20 14 32 34 50 
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Table 5. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for gestational age 
listed at the top of each column on at least two of the first three postnatal days in categories of placental histology and 
organism presence. These are row percents. 
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Placenta 
C
haracteristic 
Blood G
as Extrem
e 
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O
P Stage 
 
 
Low
est 
P
a O
2  
H
ighest 
P
a O
2  
Low
est 
PC
O
2  
H
ighest 
PC
O
2  
Low
est 
pH
 
N
 
N
one 
1 
2 
3+ 
N
 
Any 
M
ycoplasm
a 
Yes 
19 
19 
30 
15 
21 
112 
26 
21 
21 
32 
111 
 
N
o 
22 
21 
21 
23 
22 
947 
27 
22 
23 
29 
968 
 
Throm
bosis 
of fetal stem
 
vessels 
Yes 
29 
16 
23 
27 
32 
62 
35 
21 
16 
28 
57 
N
o 
22 
22 
21 
21 
21 
1009 
26 
22 
23 
29 
1040 
D
ecidual 
hem
orrhage/ 
fibrin 
deposition 
Yes 
22 
13 
19 
22 
21 
182 
16 
17 
32 
35 
179 
N
o 
22 
23 
22 
21 
22 
893 
28 
23 
21 
28 
925 
Placenta 
Characteristic 
Blood Gas Extreme ROP Stage 
 
 Lowest 
PaO2 
Highest 
PaO2 
Lowest 
PCO2 
Highest 
PCO2 
Lowest 
pH N None 1 2 3+ N 
Any 
Mycoplasma 
Yes 19 19 30 15 21 112 26 21 21 32 111  
No 22 21 21 23 22 947 27 22 23 29 968  
Thrombosis 
of fetal stem 
vessels 
Yes 29 16 23 27 32 62 35 21 16 28 57 
No 22 22 21 21 21 1009 26 22 23 29 1040 
Decidual 
hemorrhage/ 
fibrin 
deposition 
Yes 22 13 19 22 21 182 16 17 32 35 179 
No 22 23 22 2  22 89  28 23 21 28 925 
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Table 6. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for gestational age 
listed at the top of each column on at least two of the first three postnatal days in categories of infant characteristics. 
These are row percents. 
 
             !Birth weight (BW) and head circumference Z-scores based on Yudkin et al. standard 
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Infant C
haracteristic 
B
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as Extrem
e 
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O
P Stage 
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a O
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2  
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2  
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N
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3+ 
N
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23-24 
22 
21 
22 
23 
24 
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5 
14 
27 
54 
248 
25-26 
22 
20 
22 
21 
20 
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23 
22 
24 
31 
556 
27 
23 
23 
22 
23 
23 
315 
44 
27 
18 
11 
395 
B
irth w
eight 
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s) 
≤ 750  
24 
22 
22 
26 
27 
523 
10 
13 
30 
47 
443 
751-
1000 
20 
20 
22 
17 
16 
481 
28 
28 
20 
24 
519 
> 1000 
20 
22 
21 
21 
19 
168 
53 
26 
15 
7 
237 
B
W
 Z score
! 
< -2 
23 
22 
27 
27 
38 
78 
12 
17 
22 
49 
65 
< -1 
29 
25 
25 
32 
28 
173 
13 
17 
31 
39 
155 
≥ -1 
21 
20 
21 
20 
19 
921 
29 
23 
22 
26 
979 
H
ead 
circum
ference 
Z score
! 
< -2 
25 
24 
21 
28 
29 
105 
15 
13 
32 
40 
91 
< -1 
23 
20 
28 
23 
25 
253 
22 
19 
26 
33 
258 
≥ -1 
20 
22 
21 
20 
19 
773 
29 
23 
21 
27 
807 
Infant Characteristic Blood Gas Extreme ROP Stage 
 
 Lowest 
PaO2 
Highest 
PaO2 
Lowest 
PCO2 
Highest 
PCO2 
Lowest 
pH N None 1 2 3+ N 
Gestational 
age (weeks) 
23-24 22 21 22 23 24 321 5 14 27 54 248 
25-26 22 20 22 21 20 536 23 22 24 31 556 
27 23 23 22 23 23 315 44 27 18 11 395 
Birth weight 
(grams) 
≤ 750  24 22 22 26 27 523 10 13 30 47 443 
751-
1000 20 20 22 17 16 481 28 28 20 24 519 
> 1000 20 22 21 21 19 168 53 26 15 7 237 
BW Z score! 
< -2 23 22 27 27 38 78 12 17 22 49 65 
< -1 29 25 25 32 28 173 13 17 31 39 155 
≥ -1 21 20 21 20 19 921 29 23 22 26 979 
Head 
circumference 
Z score! 
< -2 25 24 21 28 29 105 15 13 32 40 91 
< -1 23 20 28 23 25 253 22 19 26 33 258 
≥ -1 20 22 21 20 19 773 29 23 21 27 807 
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Table 7. The percent of children classified by their ROP status (on the left) who 
satisfied the blood gas criterion at the top of each column. These are row 
percents.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Blood Gas Extreme  
 
 
ROP severity 
Lowest 
quartile 
PaO2 
Highest 
quartile 
PaO2 
Lowest 
quartile 
PCO2 
Highest 
quartile 
PCO2 
Lowest 
quartile 
pH 
 
Row 
N 
        
Stage 3, 4, 
or 5 
Yes 20 27 24 26 25 331 
 No 23 19 21 20 20 711 
Zone 1 Yes 20 37 19 30 35 89 
 No 22 20 22 21 20 953 
Pre-
threshold  
Yes 25 31 21 33 32 174 
or threshold No 21 19 22 20 20 868 
Plus disease Yes 28 28 22 36 31 134 
 No 21 20 22 20 20 908 
        
Overall  22 21 22 22 22  
Column N  227 221 230 229 225 1042 
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Table 8. Odds ratios1 (and 95% confidence intervals) of the association between 
blood gas extremes (defined as a blood gas measure in the highest or lowest 
quartile for gestational age) and the risk of ROP. The referent group for each set 
of analyses consists of all children who did not have the ROP classification listed 
at the top of each set of columns.  
 
 
 1 All models are adjusted for maternal BMI > 30, maternal use of aspirin during 
pregnancy, WBC > 20K within 48 hours of delivery, delivery for preeclampsia or 
fetal indication, decidual hemorrhage/fibrin deposition in placenta, gestational 
age (23-24, 25-26, 27 weeks) and birth weight Z-score   < -1, definite early 
sepsis, definite late sepsis and all of the other blood gas extremes in the model. 
These models include a hospital cluster term to account for the possibility that 
infants born at a particular hospital are more like each other than like infants born 
at other hospitals. 
 
 Stage 3, 4, or 5 Zone 1 
 Blood gas Model 1 Model 2 Model 1 Model 2 
Lowest PO2 0.9 (0.6, 1.4) 1.0 (0.7, 1.5) 0.6 (0.3, 1.1) 0.6 (0.3, 1.2) 
Highest PO2 1.4 (0.95, 2.0) 1.4 (0.96, 2.0) 2.5 (1.5, 4.5) 2.5 (1.4, 4.4) 
Lowest PCO2 0.8 (0.6, 1.2) 0.8 (0.6, 1.2) 0.7 (0.4, 1.5) 0.7 (0.4, 1.4) 
Highest PCO2 1.6 (1.1, 2.3)  2.0 (1.1, 3.6)  
Lowest pH  1.4 (0.9, 2.0)  2.1 (1.2, 3.8) 
 Pre-threshold or threshold Plus disease 
 Blood gas Model 1 Model 2 Model 1 Model 2 
Lowest PO2 1.1 (0.7, 1.7) 1.1 (0.7, 1.8) 1.4 (0.9, 2.3) 1.5 (0.9, 2.4) 
Highest PO2 2.1 (1.3, 3.3) 2.1 (1.4, 3.3) 1.7 (1.02, 2.7) 1.7 (1.04, 2.8) 
Lowest PCO2 0.8 (0.5, 1.3) 0.8 (0.5, 1.3) 0.8 (0.5, 1.4) 0.8 (0.5, 1.4) 
Highest PCO2 1.9 (1.2, 3.0)  1.8 (1.1, 2.9)  
Lowest pH  1.8 (1.1, 2.8)  1.5 (0.9, 2.4) 
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Figure 1.  Diagram of eyes showing zones and clock hours to describe location and extent of ROP 
 
 
                        
 
 
Diagram depicting premature retina with demarcated zones. Zone I surrounds optic nerve 
head. Also denoted around perimeter are clock hours (in red) to document extent of disease. 
Retinal changes are recorded on a document such as the one above. Adapted from figure 1 
in American Academy of Pediatrics Policy Statement: Screening Examination of Premature 
Infants for Retinopathy of Prematurity (14). 
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Figure 2. Photographs of ROP stages 1, 2 and 3, and plus disease, reproduced 
with permission from figures 3,4, 6 and 10 in International Classification of 
Retinopathy of Prematurity Revisited (13). 
 
(a) ROP Stage 1 
 
 
(b) ROP Stage 2 
 
 
 
 
c) ROP Stage 3 
 
 
 
(d) Plus disease 
 
 
 
 
Pigmented fundus photographs (a, b, c) and fundus photograph (d) depicting 
stage 1 (a), stage 2 (b), stage 3 (c) ROP and plus disease (d). White arrows (a) 
indicate demarcation line between vascularized and avascular retina in ROP 
stage 1. Note progression of line into three-dimensional ridge (b) signaling 
development of stage 2 ROP and progression of stage 2 (b) to stage 3 ROP 
(c). Image (d) depicts posterior venous dilatation and arteriolar tortuosity 
characteristic of plus disease. 
 
 
 
 
Stage 2: Ridge
The ridge is the hallmark of stage 2
ROP (Figure 4 and Figure 5). It
arises in the region of the demarca-
tion line, has height and width, and
extends above the plane of the retina.
The ridgemay change fromwhite to
pink and vesselsmay leave the plane
of the retina posterior to the ridge to
enter it. Small isolated tufts of neo-
vascular tissue lying on the surface
of the retina, commonly called “pop-
corn” (Figure 5) may be seen poste-
rior to this ridge structure. Such le-
sions do not constitute the degree of
fibrovascular growth that is a neces-
sary condition for stage 3.
Stage 3: Extraretinal
Fibrovascular Proliferation
In stage 3, extraretinal fibrovascular
proliferation or neovascularization
extends from the ridge into the vit-
reous (Figure 6). This extraretinal
proliferating tissue is continuouswith
theposterior spect of the ri ge, caus-
ing a ragged appearance as the pro-
liferation becomes more extensive.
The severity of a stage 3 lesion can
be subdivided into mild, moderate,
or severe depending on the extent of
extraretinal fibrovascular tissue in-
filtrating the vitreous.
Stage 4: Partial Retinal
Detachment
Stage 4 is divided into extrafoveal
(stage 4A) and foveal (stage 4B) par-
tial retinal detachments (Figure7).
Stage 4 retinal detachments are gen-
erally concave andmost are circum-
ferentially oriented. The extent of
retinal detachment depends on the
number of clock hours of fibrovas-
cular traction and their degree of
contraction. Typically, retinal de-
tachments begin at the point of fi-
brov scular attachment to the vas-
cularized retina. In progressive cases,
the fibrous tissue continues to con-
tract and the tractional retinal de-
tachment increases in height, ex-
tending both anter ior ly and
posteriorly. Radial detachments and
more complex configurations of reti-
nal detachments are less common.
Stage 5: Total Retinal
Detachment
Retinal detachments are generally
tractional and may occasionally be
exudative (Figure8). They are usu-
ally funnel shaped. The configura-
tion of the funnel itself permits a sub-
division of this stage. The funnel is
A B
Figure 3. Fundus photograph to illustrate the demarcation line of stage 1. A, View of the demarcation line in stage 1 retinopathy of prematurity. B, Another
example of the demarcation line seen in stage 1 retinopathy of prematurity (arrows) and absence of any retinopathy of prematurity.
Figure 4. Pigmented fundus photograph showing stage 2 retinopathy of
prematurity at the junction between vascularized and avascular retina.
Figure 5. Fundus photograph showing the ridge between vascularized and
avascular retina characteristic of stage 2 retinopathy of prematurity (single
long arrow). Small isolated tufts of new vessels (popcorn) lie on the retinal
surface (short arrows). Note also stage 3 retinopathy of prematurity is
present in the left hand portion of the photograph (double long arrows).
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divided into anterior and posterior
parts. When open both anteriorly
andposteriorly, the detachment gen-
erally has a concave configuration
and extends to the optic disc. A sec-
ond frequent configuration is one in
which the funnel is narrow in both
its anterior and posterior aspects and
the detached retina is located just be-
hind the lens. A third, less com-
mon type, is one in which the fun-
nel is open anteriorly but narrowed
posteriorly. Least common is a fun-
nel that is narrow anteriorly and
open posteriorly.
PLUS DISEASE
Alongwith thechangesdescribedear-
lier at the leading edge of the abnor-
mally developing retinal vascula-
ture, additional signs indicating the
severity of active ROP may occur.
These include increased venous di-
laattion and arteriolar tortuosity of
the posterior retinal vessels andmay
later increase in severity to include
iris vascular engorgement, poor pu-
pillary dilatation (rigid pupil), and
vitreous haze. This important con-
stellation of signs in the original clas-
sification was referred to as plus
disease.(Figure9) Subsequentmul-
A B
C D
E F
Figure 6. Fundus photographs of mild to severe stage 3 retinopathy of prematurity (ROP). A, View of mild stage 3 ROP. This represents progression of the ROP imaged
in Figure 4. B, View of stage 3 moderate ROP with fingerlike extensions posterior to the ridge. Note that the posterior pole vessels show increased tortuosity and
dilatation. C, View of moderate stage 3 ROP. D, View of moderate stage 3 ROP. Substantial amounts of extraretinal fibrovascular proliferation are seen infiltrating the
vitreous posterior to the ridge. Note the tortuosity and dilatation of posterior pole vessels that are insufficient for plus disease. E, View of severe stage 3 ROP with
massive infiltration of neovascular tissue surrounding the ridge. F, View of severe stage 3 ROP with infiltration of the vitreous with a dominantly fibrotic proliferation.
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plus disease as the vessels dilate and
becomemore tortuous (Figure11).
The presence of pre-plus disease can
be noted beside the stage, for ex-
ample, stage 2 with pre-plus disease.
AGGRESSIVE POSTERIOR ROP
An uncommon, rapidly progress-
ing, severe form of ROP is desig-
nated AP-ROP. If untreated, it usu-
ally progresses to stage 5 ROP. The
characteristic features of this type of
ROP are its posterior location,
prominence of plus disease, and the
ill-defined nature of the retinopa-
thy (Figure12A). This rapidly pro-
gressing retinopathy has been re-
ferred previously as “type II ROP”
and “Rush disease,”10-12 but was not
specifically included in ICROP.2 Ag-
gressive, posterior ROP seems to be
themost appropriate term since the
diagnosis can be made on a single
visit and it does not require evalu-
ation over time.
Aggressive posterior retinopa-
thy of prematurity is observedmost
commonly in zone I, but may also
occur in posterior zone II. Early in
the development of AP-ROP, the
posterior pole vessels show in-
creased dilation and tortuosity in all
4 quadrants that is out of propor-
tion to the peripheral retinopathy.
These vascular changes progress rap-
idly. Shunting occurs from vessel to
vessel within retina and not solely
at the junction between vascular and
avascular retina.13 As a result, in AP-
ROP it is often difficult to distin-
guish between arterioles and ven-
ules because of the significant
dilation and tortuosity of both ves-
sel types. There may also be hem-
orrhages at the junction between the
vascularized and avascular retina.
Another important feature of AP-
ROP is that it usually does not
progress through the classic stages
1 to 3.14 (Figure 12B)Aggressive pos-
terior retinopathy of prematurity
may appear as only a flat network of
neovascularization at the decep-
tively featureless junction between
vascularized and nonvascularized
retina and may be easily overlooked
by a less experienced observer
(Figure 12A and B). Aggressive pos-
terior retinopathyofprematurity typi-
cally extends circumferentially and is
often accompanied by a circumfer-
ential vessel (Figure 12C). Perform-
ing indirect ophthalmoscopy with a
20-Dcondensing lens insteadof a 25-
Figure 10. Fundus
photograph of posterior
venous dilatation and
arteriolar tortuosity
characteristic of plus
disease (standard
photograph defining plus
disease reproduced with
permission from original
International Committee
for the Retinopathy of
Prematurity1).
A B C
Figure 11. Examples of pre-plus disease. A, Pre-plus disease with greater tortuosity of posterior pole vessels than normal but insufficient to be designated plus disease.
B, Another example of pre-plus disease. C, Pre-plus dis ase with insufficient dilatatio and tortuosity of vessels to be designated plus disease. Stage 2 retinopathy of
prematurity is present temporally in this image.
A B C
Figure 12. Examples of aggressive posterior retinopathy of prematurity (AP-ROP). A, View of AP-ROP. Note posterior location, prominence of plus disease, and
modest-appearing proliferative retinopathy (arrows). B, Fundus photograph of AP-ROP demonstrating plus disease associated with brushlike neovascular
proliferation at junction between vascular and avascular retina. This example of AP-ROP occurs in zone I. C, A further example of AP-ROP. Note circumferential
vessel at edge of vascularized r tina (reproduced with permission from Katz et al10).
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Stage 2: Ridge
The ridge is the hallmark of stage 2
ROP (Figure 4 and Figure 5). It
arises in the region of the demarca-
tion line, has height and width, and
extends above the plane of the retina.
The ridgemay change fromwhite to
pink and vesselsmay leave the plane
of the retina posterior to the ridge to
enter it. Small isolated tufts of neo-
vascular tissue lying on the surface
of the retina, commonly called “pop-
corn” (Figure 5) may be seen poste-
rior to this ridge structure. Such le-
sions do not cons itute the degre of
fibrovascular growth that is a neces-
sary condition for stage 3.
Stage 3: Extraretinal
Fibrovascular Proliferation
In stage 3, extraretinal fibrovascular
proliferation or neovascularization
extends from the ridge into the vit-
reous (Figure 6). This extraretinal
proliferating tissue is continuouswith
theposterior aspect of the ridge, caus-
ing a ragged appearance as the pro-
liferation becomes more extensive.
The severity of a stage 3 lesion can
be subdivided into mil , moderate,
or severe depending on the extent of
extraretinal fibrovascular tissue in-
filtrating the vitreous.
Stage 4: Partial Retinal
Detachment
Stage 4 is divided into extrafoveal
(stage 4A) and foveal (stage 4B) par-
tial retinal detachments (Figure7).
Stage 4 retinal detachments are gen-
erally concave andmost are circum-
ferentially oriented. The extent of
retinal detachment depends on the
number of clock hours of fibrovas-
cular traction and their degree of
contraction. Typically, retinal de-
tachments begin at the point of fi-
brovascular attachment to the vas-
cularized retina. In progressive cases,
the fibrous tissue continues to con-
tract and the tractional retinal de-
tachment increases in height, ex-
tending both anter ior ly and
posteriorly. Radial detachments and
more complex configurations of reti-
nal detachments are less common.
Stage 5: Total Retinal
Detachment
Retinal detachments are generally
tractional and may occasionally be
exudative (Figure8). They are usu-
ally funnel shaped. The configura-
tion of the funnel itself permits a sub-
division of this stage. The funnel is
A B
Figure 3. Fundus photograph to illustrate the demarcation line of stage 1. A, View of the demarcation line in stage 1 retinopathy of prematurity. B, Another
example of the demarcation line seen in stage 1 retinopathy of prematurity (arrows) and absence of any retinopathy of prematurity.
Figure 4. Pigmented fundus photograph showing stage 2 retinopathy of
prematurity at the junction between vascularized and avascular reti a.
Figure 5. Fundus photograph showing the ridge between vascularized and
avascular retina charact ristic of tage 2 retinopathy of prematurity (single
long arrow). Small isolated tufts of new vessels (popcorn) lie on the retinal
surface (short arrows). Note also stage 3 retinopathy of prematurity is
present in the left hand portion of the photograph (double long arrows).
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Figure 3. Correlation between highest PaO2, highest PCO2 and lowest pH to 
ROP stage 
 
 
(a)     Highest PaO2 and ROP Stage  
         
 
 
 
 
(b)    Highest PCO2 and ROP Stage 
         
 
 
 
 Hauspurg et al. Neonatology 2011;99:104–111106
 We collected the minimum and maximum blood gas values 
each day. Because we cannot tell if extreme pH and PCO 2 mea-
surements are paired, we did not calculate base excess. We did not 
require any blood gases to be taken as per protocol. All measure-
ments were taken at the discretion of the attending physician. 
Thus, there is no standardized frequency of blood gas measure-
ments in this study.
 Eye Examinations 
 Participating ophthalmologists helped prepare a manual and 
data collection form, and then participated in efforts to minimize 
observer variability. Definitions of terms were those accepted by 
the International Committee for Classification of ROP  [20] .
 ELGAN ophthalmologists used indirect ophthalmoscopy. 
Only one of our sites used RetCam with any frequency.  In keeping 
with guidelines  [21] , the first ophthalmologic examination was 
within the 31st to 33rd postmenstrual week.  In accordance with 
follow-up examination guidelines, infants at high risk of ROP 
were examined weekly, while those with no ROP present at first 
examination were re-examined every 2–3 weeks. Photographs 
were encouraged in case of doubt about classification. We did not 
include information about treatment because Early Treatment for 
ROP (ETROP) guidelines, including suggested policy changes, 
were released during the recruitment phase  [22] .
 Data Analysis 
 The generalized form of the null hypothesis we evaluated is 
that children who have a blood gas in an extreme quartile on 2 of 
the first 3 postnatal days are not at higher risk of severe ROP than 
children who did not have that blood gas extreme on 2 of the first 
3 postnatal days. We evaluated five blood gas extremes (lowest 
quartile of PaO 2 , highest quartile of PaO 2 , lowest quartile of PCO 2 , 
highest quartile of PCO 2 , lowest quartile of pH) in models that 
included the three of the other four blood gas extremes as well as 
other confounders. Confounders were selected by their associa-
tion with a blood gas extreme and stage 3 or higher ROP, biologic 
plausibility or previous identification in the literature ( table 2 ). All 
conditional logistic multivariable models included a hospital clus-
ter term (to account for the possibility that infants born at a par-
ticular hospital are more like each other than like infants born at 
other hospitals)  [23] . The contributions of relevant variables are 
presented as risk ratios with 95% confidence intervals.
 In this sample, children who had a PCO 2 in the highest quar-
tile tended to have a pH in the lowest quartile more commonly 
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 Fig. 1. Box-and-whisker plots of highest PaO 2 ( a ), highest PCO 2 
( b ), and lowest pH ( c ) on each postnatal day of infants with no 
ROP, stage 1–2 ROP, and stage 3–5 ROP. The median is indicated 
by the line closest to the middle of the box, while the top and bot-
tom of the box indicate the 25th and 75th centiles. The dispersion 
of blood gases is indicated by the length of the vertical lines ema-
nating from each box, as well as the black dots, which identify 
outliers. 
 Hauspurg et al. Neonatology 2011;99:104–111106
 We collected the minimum and maximum blood gas values 
each day. Because we cannot tell if extreme pH and PCO 2 mea-
surements are paired, we did not calculate base excess. We did not 
require any blood gases to be taken as per protocol. All measure-
ments were taken at the discretion of the attending physician. 
Thus, there is no standardized frequency of blood gas measure-
ments in this study.
 Eye Examinations 
 Participating ophthalmologists helped prepare a manual and 
data collection form, and then participated in efforts to minimize 
observer variability. Definitions of terms were those accepted by 
the International Committee for Classification of ROP  [20] .
 ELGAN ophthalmologists used indirect ophthalmoscopy. 
Only one of our sites used RetCam with any frequency.  In keeping 
with guidelines  [21] , the first ophthalmologic examination was 
within the 31st to 33rd postmenstrual week.  In accordance with 
follow-up examination guidelines, infants at high risk of ROP 
were examined weekly, while those with no ROP present at first 
examination were re-examined every 2–3 weeks. Photographs 
were encouraged in case of doubt about classification. We did not 
include information about treatment because Early Treatment for 
ROP (ETROP) guidelines, including suggested policy changes, 
were released during the recruitment phase  [22] .
 Data Analysis 
 The generalized form of the null hypothesis we evaluated is 
that children who have a blood gas in an extreme quartile on 2 of 
the first 3 postnatal days are not at higher risk of severe ROP than 
children who did not have that blood gas extreme on 2 of the first 
3 postnatal days. We evaluated five blood gas extremes (lowest 
quartile of PaO 2 , highest quartile of PaO 2 , lowest quartile of PCO 2 , 
highest quartile of PCO 2 , lowest quartile of pH) in models that 
included the three of the other four blood gas extremes as well as 
other confounders. Confounders were selected by their associa-
tion with a blood gas extreme and stage 3 or higher ROP, biologic 
plausibility or previous identification in the literature ( table 2 ). All 
conditional logistic multivariable models included a hospital clus-
ter term (to account for the possibility that infants born at a par-
ticular hospital are more like each other than like infants born at 
other hospitals)  [23] . The contributions of relevant variables are 
presented as risk ratios with 95% confidence intervals.
 In this sample, children who had a PCO 2 in the highest quar-
tile tended to have a pH in the lowest quartile more commonly 
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 Fig. 1. Box-and-whisker plots of highest PaO 2 ( a ), highest PCO 2 
( b ), and lowest pH ( c ) on each postnatal day of infants with no 
ROP, stage 1–2 ROP, and stage 3–5 ROP. The median is indicated 
by the line closest to the middle of the box, while the top and bot-
tom of the box indicate the 25th and 75th centiles. The dispersion 
of blood gases is indicated by the length of the vertical lines ema-
nating from each box, as well as the black dots, which identify 
outliers. 
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centiles. The dispersion of blood gases is indicated by the length of the 
vertical lines emanating from each box, as well as the black dots, which 
identify outliers. 
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 We collected the minimum and maximum blood gas values 
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surements are paired, we did not calculate base excess. We did not 
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ments were taken at the discretion of the attending physician. 
Thus, there is no standardized frequency of blood gas measure-
ments in this study.
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Only one of our sites used RetCam with any frequency.  In keeping 
with guidelines  [21] , the first ophthalmologic examination was 
within the 31st to 33rd postmenstrual week.  In accordance with 
follow-up examination guidelines, infants at high risk of ROP 
were examined weekly, while those with no ROP present at first 
examination were re-examined every 2–3 weeks. Photographs 
were encouraged in case of doubt about classification. We did not 
include information about treatment because Early Treatment for 
ROP (ETROP) guidelines, including suggested policy changes, 
were released during the recruitment phase  [22] .
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that children who have a blood gas in an extreme quartile on 2 of 
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included the three of the other four blood gas extremes as well as 
other confounders. Confounders were selected by their associa-
tion with a blood gas extreme and stage 3 or higher ROP, biologic 
plausibility or previous identification in the literature ( table 2 ). All 
conditional logistic multivariable models included a hospital clus-
ter term (to account for the possibility that infants born at a par-
ticular hospital are more like each other than like infants born at 
other hospitals)  [23] . The contributions of relevant variables are 
presented as risk ratios with 95% confidence intervals.
 In this sample, children who had a PCO 2 in the highest quar-
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 Fig. 1. Box-and-whisker plots of highest PaO 2 ( a ), highest PCO 2 
( b ), and lowest pH ( c ) on each postnatal day of infants with no 
ROP, stage 1–2 ROP, and stage 3–5 ROP. The median is indicated 
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tom of the box indicate the 25th and 75th centiles. The dispersion 
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